申请人:GANT Thomas G.
公开号:US20080045558A1
公开(公告)日:2008-02-21
The present disclosure is directed to modulators of opiate- and/or NMDA receptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the use of such compounds for the treatment and/or management of pain, anxiety, neurodegeneration, drug dependence, coughing, muscular tension, and/or glaucoma and any other condition in which it is beneficial to modulate an opiate- and/or NMDA receptor.
本公开涉及阿片和/或NMDA受体的调节剂及其药用盐和前药,其化学合成,以及利用这些化合物治疗和/或管理疼痛、焦虑、神经退行性疾病、药物依赖、咳嗽、肌肉紧张、和/或青光眼以及任何其他有益于调节阿片和/或NMDA受体的情况。